UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 178

Sortiert nach

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington’s Disease

Molecular neurobiology, 2018-11, Vol.55 (11), p.8263-8277

2018

Volltextzugriff (PDF)

The expanding clinical profile of anti-AMPA receptor encephalitis

Neurology, 2010-03, Vol.74 (10), p.857

2010

Volltextzugriff (PDF)

Deficits in coordinated neuronal activity and network topology are striatal hallmarks in Huntington's disease

BMC biology, 2020-05, Vol.18 (1), p.58-58, Article 58

2020

Volltextzugriff (PDF)

Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity

Human molecular genetics, 2012-03, Vol.21 (6), p.1203-1216

2012

Volltextzugriff (PDF)

Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies

Cell death & disease, 2013-04, Vol.4, p.e595

2013

Volltextzugriff (PDF)

BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease

Gene therapy, 2010-10, Vol.17 (10), p.1294-1308

2010

Volltextzugriff (PDF)

Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: Involvement of phospholipaseCγ activity and glutamate receptor expression

Neuroscience, 2009-02, Vol.158 (4), p.1234-1250

2009

Volltextzugriff (PDF)

Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells

Gene therapy, 2007-01, Vol.14 (2), p.118-128

2007

Volltextzugriff (PDF)

B10 Nuclear Lamina Is Differentially Altered In Huntington’s Disease Brain Regions

Journal of neurology, neurosurgery and psychiatry, 2014-09, Vol.85 (Suppl 1), p.A12-A12

2014

Volltextzugriff (PDF)

Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease

Cell death & disease, 2014-08, Vol.5 (8), p.e1364-e1364

2014

Volltextzugriff (PDF)

PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K Akt pro-survival pathway in Huntington's disease striatum

Cell death and differentiation, 2010-02, Vol.17 (2), p.324-335

2010

Volltextzugriff (PDF)

Brain‐Derived Neurotrophic Factor, Neurotrophin‐3, and Neurotrophin‐4/5 Prevent the Death of Striatal Projection Neurons in a Rodent Model of Huntington's Disease

Journal of neurochemistry, 2000-11, Vol.75 (5), p.2190-2199

2000

Volltextzugriff (PDF)

Long-Term Expression of Erythropoietin from Myoblasts Immobilized in Biocompatible and Neovascularized Microcapsules

Molecular therapy, 2005-08, Vol.12 (2), p.283-289

2005

Volltextzugriff (PDF)

Effect of glatiramer acetate (Copaxone ®) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: A longitudinal study

Neuroscience letters, 2006-10, Vol.406 (3), p.270-275

2006

Volltextzugriff (PDF)

B22 Normalisation Of Aberrant P75NTR Levels Prevents Hippocampal Synaptic And Cognitive Deficits And Ameliorates Cortico-striatal Dysfunction In Huntington Disease

Journal of neurology, neurosurgery and psychiatry, 2014-09, Vol.85 (Suppl 1), p.A16-A17

2014

Volltextzugriff (PDF)

The dopaminergic stabilizer, (−)-OSU6162, rescues striatal neurons with normal and expanded polyglutamine chains in huntingtin protein from exposure to free radicals and mitochondrial toxins

Brain research, 2012-06, Vol.1459, p.100-112

2012

Volltextzugriff (PDF)

Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington’s disease

Brain research bulletin, 2002-04, Vol.57 (6), p.817-822

2002

Volltextzugriff (PDF)

Les conflits d’archives: France, Espagne, Méditerranée

2022

Volltextzugriff (PDF)

Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease

Histology and histopathology, 2006-11, Vol.21 (11), p.1217

2006

Volltextzugriff (PDF)

Imbalance of p75NTR/TrkB protein expression in Huntington’s disease: implication for neuroprotective therapies

Cell death & disease, 2013-04, Vol.4 (4), p.e595-e595

2013

Volltextzugriff (PDF)

Association between BDNF Val66Met polymorphism and age at onset in Huntington disease

Neurology, 2005-09, Vol.65 (6), p.964

2005

Volltextzugriff (PDF)

Analysis of antibodies to neuronal surface antigens in adult opsoclonus–myoclonus

Journal of neuroimmunology, 2008-05, Vol.196 (1), p.188-191

2008

Volltextzugriff (PDF)

Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington’s Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus Accumbens

Biological psychiatry (1969), 2019-08, Vol.86 (3), p.196-207

2019

Volltextzugriff (PDF)

Porous anodic oxides on titanium and on a Ti–W alloy

Corrosion science, 2008-02, Vol.50 (2), p.548-553

2008

Volltextzugriff (PDF)

Bone morphogenetic protein-6 is a neurotrophic factor for calbindin-positive striatal neurons

Journal of neuroscience research, 2002-12, Vol.70 (5), p.638-644

2002

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(166)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(113)
Life Sciences & Biomedicine
(109)
Animals
(94)
Neurosciences
(82)
Neurosciences & Neurology
(82)
Rats
(53)
Biological And Medical Sciences
(50)
Male
(47)
Mice
(43)
Fundamental And Applied Biological Sciences. Psychology
(34)
Humans
(30)
Rats, Sprague-Dawley
(28)
Vertebrates: Nervous System And Sense Organs
(27)
Neurons - Metabolism
(26)
Disease Models, Animal
(23)
Neurology
(22)
Neurons - Drug Effects
(22)
Cells, Cultured
(21)
Female
(21)
Medical Sciences
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington’s Disease

The expanding clinical profile of anti-AMPA receptor encephalitis

Deficits in coordinated neuronal activity and network topology are striatal hallmarks in Huntington's disease

Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity

Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies

BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease

Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: Involvement of phospholipaseCγ activity and glutamate receptor expression

Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells

B10 Nuclear Lamina Is Differentially Altered In Huntington’s Disease Brain Regions

Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease

PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K Akt pro-survival pathway in Huntington's disease striatum

Brain‐Derived Neurotrophic Factor, Neurotrophin‐3, and Neurotrophin‐4/5 Prevent the Death of Striatal Projection Neurons in a Rodent Model of Huntington's Disease

Long-Term Expression of Erythropoietin from Myoblasts Immobilized in Biocompatible and Neovascularized Microcapsules

Effect of glatiramer acetate (Copaxone ®) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: A longitudinal study

B22 Normalisation Of Aberrant P75NTR Levels Prevents Hippocampal Synaptic And Cognitive Deficits And Ameliorates Cortico-striatal Dysfunction In Huntington Disease

The dopaminergic stabilizer, (−)-OSU6162, rescues striatal neurons with normal and expanded polyglutamine chains in huntingtin protein from exposure to free radicals and mitochondrial toxins

Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington’s disease

Les conflits d’archives: France, Espagne, Méditerranée

Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease

Imbalance of p75NTR/TrkB protein expression in Huntington’s disease: implication for neuroprotective therapies

Association between BDNF Val66Met polymorphism and age at onset in Huntington disease

Analysis of antibodies to neuronal surface antigens in adult opsoclonus–myoclonus

Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington’s Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus Accumbens

Porous anodic oxides on titanium and on a Ti–W alloy

Bone morphogenetic protein-6 is a neurotrophic factor for calbindin-positive striatal neurons

Suchergebnisse filtern